Global private equity and venture capital news and research

Carlyle in talks to buy Elder Pharmaceuticals unit for up to $450m

24 Jul 2013

pharmaceutical 12_sqBuyout major Carlyle is reportedly in talks to acquire the domestic drug formulations business of Indian company Elder Pharmaceuticals for $400m to $450m.

Carlyle is competing with healthcare group Sanofi’s Indian unit, which is in separate talks to buy the division, said Reuters, citing three sources with knowledge of the matter.

A deal could be sealed as soon as next month, said one of the sources.

Earlier this month Elder approved restructuring of the business by either raising capital or selling assets to reduce its debt pile.

Earlier this year Carlyle revealed plans to raise a fund targeting Indian businesses and launch a non banking financial company.

The fund is expected to target the retail, defence and insurance that don’t get much attention from foreign investors, said the Economic Times.

Copyright © 2013 AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016